CoChat
Cited by 199

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Review of methods for detecting glycemic disorders

Open access
Bergman, Michael, Abdul-Ghani, Muhammad, DeFronzo, Ralph A., Manco, Melania, Sesti, Giorgio, Fiorentino, Teresa Vanessa, Ceriello, Antonio, Rhee, Mary, Phillips, Lawrence S., Chung, Stephanie, Cravalho, Celeste, Jagannathan, Ram, Monnier, Louis, Colette, Claude, Owens, David, Bianchi, Cristina, del Prato, Stefano, Monteiro, Mariana P., Neves, João Sérgio, Medina, Jose Luiz, Macedo, Maria Paula, Ribeiro, Rogério Tavares, Filipe Raposo, João, Dorcely, Brenda, Ibrahim, Nouran, Buysschaert, Martin · 2020 · Diabetes Research and Clinical Practice

Abstract

Prediabetes (intermediate hyperglycemia) consists of two abnormalities, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) detected by a standardized 75-gram oral glucose tolerance test (OGTT). Individuals with isolated IGT or combined IFG and IGT have increased risk for developing type 2 diabetes (T2D) and cardiovascular disease (CVD). Diagnosing prediabetes early and accurately is critical in order to refer high-risk individuals for intensive lifestyle modification. However, there is currently no international consensus for diagnosing prediabetes with HbA1c or glucose measurements based upon American Diabetes Association (ADA) and the World Health Organization (WHO) criteria that identify different populations at risk for progressing to diabetes. Various caveats affecting the accuracy of interpreting the HbA1c including genetics complicate this further. This review describes established methods for detecting glucose disorders based upon glucose and HbA1c parameters as well as novel approaches including the 1-hour plasma glucose (1-h PG), glucose challenge test (GCT), shape of the glucose curve, genetics, continuous glucose monitoring (CGM), measures of insulin secretion and sensitivity, metabolomics, and ancillary tools such as fructosamine, glycated albumin (GA), 1,5- anhydroglucitol (1,5-AG). Of the approaches considered, the 1-h PG has considerable potential as a biomarker for detecting glucose disorders if confirmed by additional data including health economic analysis. Whether the 1-h OGTT is superior to genetics and omics in providing greater precision for individualized treatment requires further investigation. These methods will need to demonstrate substantially superiority to simpler tools for detecting glucose disorders to justify their cost and complexity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2020.108233

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 199

Metadata

Authors
Bergman, M., Abdul-Ghani, M., DeFronzo, R. A., Manco, M., Sesti, G., Fiorentino, T. V., Ceriello, A., Rhee, M., Phillips, L. S., Chung, S., Cravalho, C., Jagannathan, R., Monnier, L., Colette, C., Owens, D., Bianchi, C., del Prato, S., Monteiro, M. P., Neves, J. S., Medina, J. L., Macedo, M. P., Ribeiro, R. T., Filipe Raposo, J., Dorcely, B., Ibrahim, N., & Buysschaert, M.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2020-07
Volume
165
Pages
108233
ISSN
0168-8227 (ISSN-L)
OpenAlex
W3032874471
Cited by
199
References
75
FWCI
17.99
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review of methods for detecting glycemic disorders. https://app.cochat.ai/papers/10.1016/j.diabres.2020.108233
The paper
Bergman, M., Abdul-Ghani, M., DeFronzo, R. A., Manco, M., Sesti, G., Fiorentino, T. V., Ceriello, A., Rhee, M., Phillips, L. S., Chung, S., Cravalho, C., Jagannathan, R., Monnier, L., Colette, C., Owens, D., Bianchi, C., del Prato, S., Monteiro, M. P., Neves, J. S., . . . Buysschaert, M. (2020). Review of methods for detecting glycemic disorders. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2020.108233

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.